Work

A phase II study of alternative sunitinib scheduling in patients with metastatic renal cell carcinoma.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.6_suppl.533

Authors: Eric Jonasch, Rebecca Slack, Daniel M. Geynisman, Matthew I. Milowsky, Kimryn Rathmell, Summer Stovall, Donna Juarez, Elizabeth R. Plimack, Nizar M. Tannir, Brian I. Rini

Institutions: The University of Texas MD Anderson Cancer Center, Fox Chase Cancer Center, University of North Carolina at Chapel Hill, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Cleveland Clinic

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2603963110

Cites:

Cited by: 1

Related to: 10